4 Things Working With HIV Can Teach Us About Fighting Ebola

(RNS) Every year on Dec. 1, World AIDS Day focuses attention on the disease that last year infected another 2.1 million people and took more than 1.5 million lives, according to UNAIDS. After 26 years of World AIDS Days, the death toll stands at a staggering 39 million. And yet, within the HIV/AIDS community there is optimism. Many believe new infections can be stopped completely, and the annual death toll has been cut in half… (read mo...

Continue reading

Is the Blood of Ebola Survivors an Effective Treatment?

When the World Health Organization recently named blood transfusions from Ebola survivors as its priority experimental therapy for the disease ravaging west Africa there was only one major problem: no data indicating that such transfusions work. Blood plasma from survivors contains antibodies that could potentially trigger an immune system response in patients, which would bolster their ability to fight the virus, but clinical data suggesting...

Continue reading

Ebola In The Air: What Science Says About How The Virus Spreads

Here’s an Ebola puzzle for you: If the virus isn’t airborne, why do doctors and nurses need to wear full protective suits, with face masks, while treating patients? After we dug through studies and talked to scientists, the answer slowly emerged. Ebola does spread through the air. But not through the airborne route… (read more)

Continue reading

WHO says Sierra Leone prognosis ‘very good’ against Ebola

(Reuters) – Sierra Leone does not yet have enough beds in treatment centers to isolate Ebola patients in the west of the country but many new facilities should be opened in the next few weeks, the World Health Organization’s assistant director general said on Monday. “That capacity (to treat Ebola) at the district level is strong and getting stronger in Sierra Leone, and that’s why I think the prognosis is actually very...

Continue reading

Ebola vaccine from Glaxo passes early safety test

(Reuters) – An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine. The trial, which began on Sept. 2 and will monitor the volunteers for 48 weeks, is primarily aimed at assessing how safe the vaccine is. But the immune response...

Continue reading

No more Ebola cases in Mali after patient cured: President

(Reuters) – Mali has no more confirmed cases of Ebola after the last patient known to be suffering from the virus was cured, President Ibrahim Boubacar Keita said on Saturday. Mali has registered eight cases of Ebola – seven of them confirmed and one probable – after the virus spread from neighboring Guinea, the World Health Organization (WHO) said this week… (read more)  

Continue reading

US Ebola survivors meet on TODAY

Six American Ebola survivors, meeting together for the first time as a group Wednesday on TODAY, opened up about the unusual bond they share and the unique reasons they have to be thankful this holiday season. Many thanked Dr. Kent Brantly, one of the first survivors to recover and who then went on to donate his plasma to most of the others as they recuperated… (read more)

Continue reading

NYC WOMAN ON EBOLA WATCHLIST DIES BLEEDING FROM MOUTH, AUTHORITIES SAY “HEART ATTACK”

                    A woman who returned from Guinea 18 days ago and was on an Ebola monitoring list dropped dead in a Brooklyn hair salon yesterday after eyewitnesses said she began bleeding from the mouth and nose, but authorities later asserted the cause of death was an “apparent heart attack.” “FDNY activated the Special Operations and Hazmat units after the the woman, who had traveled to Guinea...

Continue reading